• Explore /
  • Poster
  • / SWOG S1931 (PROBE): Phase III randomized trial of immune checkpoint inhibitor (ICI) combination regimen with or without cytoreductive nephrectomy (CN) in advanced renal cancer.

SWOG S1931 (PROBE): Phase III randomized trial of immune checkpoint inhibitor (ICI) combination regimen with or without cytoreductive nephrectomy (CN) in advanced renal cancer.

Abstract Poster

Authors

Ulka Vaishampayan

Ulka N. Vaishampayan

University of Michigan Cancer Center, Detroit, MI

Ulka N. Vaishampayan , Catherine Tangen , Abhishek Tripathi , Brian M. Shuch , Sumanta K. Pal , Pedro C. Barata , Alan Tan , Peggy Zuckerman , Edward Mayerson , Primo "Lucky" N. Lara Jr., Neeraj Agarwal , Nicholas J. Vogelzang , Hyung Lae Kim , Ian Murchie Thompson Jr.

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral, and Testicular Cancers

Track

Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT04510597

Citation

J Clin Oncol 40, 2022 (suppl 6; abstr TPS402)

DOI

10.1200/JCO.2022.40.6_suppl.TPS402

Abstract #

TPS402

Poster Bd #

M6

Abstract Disclosures

Similar Posters

First Author: Viktor Grünwald

First Author: Pratik Rane

First Author: Bradley Alexander McGregor

First Author: Kevin Yan